Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN UGANDAWhile geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Uganda may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. With regards to assessing risks in the Ugandan healthcare sector, we have identified industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) and those emanating from the state's political/economic profile (such as high inflation) that call into question the likelihood of anticipated returns being realised over the assessed time period.Headline Expenditure ProjectionsPharmaceuticals: UGX676bn (US$268mn) in 2011 to UGX794bn (US$322mn) in 2012; +14.8% growth in local currency terms and +17.3% in US dollar terms.Healthcare: UGX3,942bn (US$1.56bn) in 2011 to UGX4,519bn (US$1.83bn) in 2012; 14.6% growth in local currency terms and 17.1% in US dollar terms.Risk/Reward Rating s : In BMI's Q1 13 BERs, Uganda is ranked 24th in the Middle East and Africa (MEA) region. While factors such as population growth and increasing healthcare needs will create a growing demand for pharmaceuticals, we note that a sizeable counterfeiting industry, poor healthcare funding, corruption, regulatory environment deficiencies and a number of other issues will conspire to keep Uganda in a similarly low position in the MEA matrix over the coming months.Competitive LandscapeThe competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Uganda
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UGANDA
While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as
Uganda may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the
rewards and the risks present in a market. With regards to assessing risks in the Ugandan healthcare sector, we have identified
industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) and those emanating from the
state's political/economic profile (such as high inflation) that call into question the likelihood of anticipated returns being realised over
the assessed time period.
Headline Expenditure Projections
Pharmaceuticals: UGX676bn (US$268mn) in 2011 to UGX794bn (US$322mn) in 2012; +14.8% growth in local currency terms and
+17.3% in US dollar terms.
Healthcare: UGX3,942bn (US$1.56bn) in 2011 to UGX4,519bn (US$1.83bn) in 2012; 14.6% growth in local currency terms and
17.1% in US dollar terms.
Risk/Reward Rating s : In BMI's Q1 13 BERs, Uganda is ranked 24th in the Middle East and Africa (MEA) region. While factors such
as population growth and increasing healthcare needs will create a growing demand for pharmaceuticals, we note that a sizeable
counterfeiting industry, poor healthcare funding, corruption, regulatory environment deficiencies and a number of other issues will
conspire to keep Uganda in a similarly low position in the MEA matrix over the coming months.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
Pharmaceutical Risk/Reward Ratings 7
Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113 7
Rewards 9
Risks 9
Market Summary 10
Regulatory Regime 12
The Pharmaceutical Market: Uganda (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Intellectual Property Issues 12
Healthcare Provision 12
Epidemiology 15
Industry Forecast Scenario 17
Pharmaceutical Market Forecast 17
Table: Pharmaceutical Sales Indicators 2008-2016 18
Healthcare Market Forecast 19
Table: Healthcare Expenditure Indicators 2008-2016 22
Table: Healthcare Governmental Indicators 2008-2016 22
Table: Healthcare Private Indicators 2008-2016 23
Macroeconomic Outlook 24
Table: A Rough Fiscal Year 28
Table: Uganda - Economic Activity 28
Demographic Outlook 29
Table: Uganda's Population By Age Group, 1990-2020 ('000) 30
Table: Uganda's Population By Age Group, 1990-2020 (% of total) 31
Table: Uganda's Key Population Ratios, 1990-2020 32
Table: Uganda's Rural And Urban Population, 1990-2020 32
Glossary 33
BMI Methodology 35
How We Generate Our Pharmaceutical Industry Forecasts 35
Pharmaceuticals Risk/Reward Ratings Methodology 36
Ratings Overview 36
Table: Pharmaceutical Business Environment Indicators 37
Weighting 38
Table: Weighting Of Components 38
Sources 38
The Pharmaceutical Market: Uganda (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Uganda
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Uganda (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Uganda (From Slideshare) Page 4/4